Does COVID-19 vaccination protect against pulmonary embolism?
Tóm tắt
The prevalence of venous thromboembolism (VTE) in COVID-19 patients is highly variable, depending on methodological and clinical factors, among which vaccination (1). The hypothesis of a possible protective role of vaccination in preventing pulmonary embolism (PE) in hospitalized COVID-19 patients has not been explored. The aim of the study was to evaluate PE prevalence in vaccinated versus unvaccinated hospitalized COVID-19 patients. We conducted a retrospective case–control study from 2021/11/01 to 2022/01/15; we reviewed all the chest computed topographies (chest-CT) performed because of a clinical suspicion for PE at our Institution. Sixty-two patients were included in the study: 27/62 (43.5%) were vaccinated and 35/62 (56.4%) were not. Vaccinated patients were older and with more comorbidities than unvaccinated people. Overall, PE was diagnosed in 19/62 patients (30.1% prevalence). CT Severity Score (CT-SS) differs between the two groups; not vaccinated patients had a more severe CT imaging than the vaccinated (< 0.00005). PE prevalence in ICU was 43.2% (16/37 patients), while in the Internal Medicine ward, it was 12% (3/25 cases). PE was significantly higher among unvaccinated people: 16/35 (45.7%) vs 3/27 (11.1%), OR p = 0.04. We observed a strong association between vaccination and protection from PE in hospitalized COVID-19 patients: morbidity was significantly lower in vaccinated versus not vaccinated patients. The issue of the protective role of vaccination in COVID-19-associated VTE should be addressed in adequately designed and powered future prospective studies.
Tài liệu tham khảo
Nab L, Groenwold RHH, Klok FA, Bhoelan S, Kruip MJHA, Cannegieter SC (2022) Estimating incidence of venous thromboembolism in COVID-19: Methodological considerations. Res Pract Thromb Haemost 6(6):e12776
Xie J, Prats-Uribe A, Feng Q et al (2022) Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19. JAMA Intern Med 182(10):1063–1070
Lieveld AWE, Azijli K, Teunissen BP et al (2021) Chest CT in COVID-19 at the ED: Validation of the COVID-19 Reporting and Data System (CO-RADS) and CT Severity Score: a Prospective, Multicenter Observational Study. Chest 159(3):1126–1135
Kuswardhani RAT, Henrina J, Pranata R, Lim MA, Lawrensia S, Suastika K (2020) Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Metab Syndr Nov-Dec 14(6):2103–2109
Conway EM, Mackman N, Warren RQ et al (2022) Understanding COVID-19-associated coagulopathy. Nat Rev Immunol 22(10):639–649
Agrati C, Carsetti R, Bordoni V et al (2022) The immune response as a double-edged sword: the lesson learnt during the COVID-19 pandemic. Immunology 167(3):287–302
Bozzani A, Cutti S, Arici V, Ragni F, Sterpetti AV, Arbustini E (2023) Venous thromboembolism in hospitalized coronavirus disease 2019 patients stratified by vaccination status. J Vasc Surg Venous Lymphat Disord 11(2):473–474
Houghton DE, Wysokinski W, Casanegra AI et al (2022) Risk of venous thromboembolism after COVID-19 vaccination. J Thromb Haemost 20(7):1638–1644
Law N, Chan J, Kelly C, Auffermann WF, Dunn DP (2022) Incidence of pulmonary embolism in COVID-19 infection in the ED: ancestral, Delta Omicron variants and vaccines. Emerg Radiol 29(4):625–629. https://doi.org/10.1007/s10140-022-02039-z
Graña C, Ghosn L, Evrenoglou T et al (2022) Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst Rev 7(12):CD015477
Adhikari B, YeongCheah P, von Seidlein L (2022) Trust is the common denominator for COVID-19 vaccine acceptance: a literature review. Vaccine X 12:100213